American journal of ophthalmology case reports · 2025
Descemet's membrane endothelial keratoplasty with scraping without descemetorhexis (DMEK-SWD) in a failed penetrating keratoplasty.
Клинический случайСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wallace Alexander, Parekh Mohit, Vaccaro Sabrina, Semeraro Francesco, Romano Vito
Аннотация
PURPOSE: To introduce a novel treatment for a secondary failed penetrating keratoplasty (PK), termed Descemet's Membrane Endothelial Keratoplasty with endothelial scraping and without descemetorhexis (DMEK-SWD), through the presentation of two clinical cases.
OBSERVATIONS: In this prospective, single-center case series, two patients with previous PK for keratoconus developed endothelial decompensation, presenting with decreased visual acuity (Patient A: counting fingers; Patient B: 0.8 logMAR) and increased central corneal thickness (A: 735 μm; B: 653 μm). DMEK-SWD was performed using a 7.5-mm cell scraper through the temporal port to mechanically remove the host endothelium. A pre-stripped 7.5-mm DMEK graft was inserted using a standardized no-touch technique. Postoperative management included subconjunctival injections of gentamycin and dexamethasone. Graft attachment was maintained in both cases, although Patient B required single rebubbling procedure.Postoperative graft endothelial cell density (ECD), measured from confocal imaging (HRT3-RCM Cell Count), was 1,125 cells/mm2 at 12 months in Patient A and 1,544 cells/mm2 at 8 months in Patient B. At final follow-up (A: 18 months; B: 8 months), both patients showed improved best-corrected visual acuity (A: 0.2 logMAR; B: 0 logMAR) and reduced CCT (A: 496 μm; B: 505 μm).
CONCLUSIONS AND IMPORTANCE: This pilot study demonstrates the feasibility of DMEK-SWD in treating failed PK, with a mean graft clearance time of 1.5 weeks for the two cases analyzed. The technique may represent a promising alternative to repeat full-thickness transplantation and supports further investigation in larger cohorts. Given the very small sample size and the incomplete availability of endothelial cell count data, these findings should be regarded as preliminary.
OBSERVATIONS: In this prospective, single-center case series, two patients with previous PK for keratoconus developed endothelial decompensation, presenting with decreased visual acuity (Patient A: counting fingers; Patient B: 0.8 logMAR) and increased central corneal thickness (A: 735 μm; B: 653 μm). DMEK-SWD was performed using a 7.5-mm cell scraper through the temporal port to mechanically remove the host endothelium. A pre-stripped 7.5-mm DMEK graft was inserted using a standardized no-touch technique. Postoperative management included subconjunctival injections of gentamycin and dexamethasone. Graft attachment was maintained in both cases, although Patient B required single rebubbling procedure.Postoperative graft endothelial cell density (ECD), measured from confocal imaging (HRT3-RCM Cell Count), was 1,125 cells/mm2 at 12 months in Patient A and 1,544 cells/mm2 at 8 months in Patient B. At final follow-up (A: 18 months; B: 8 months), both patients showed improved best-corrected visual acuity (A: 0.2 logMAR; B: 0 logMAR) and reduced CCT (A: 496 μm; B: 505 μm).
CONCLUSIONS AND IMPORTANCE: This pilot study demonstrates the feasibility of DMEK-SWD in treating failed PK, with a mean graft clearance time of 1.5 weeks for the two cases analyzed. The technique may represent a promising alternative to repeat full-thickness transplantation and supports further investigation in larger cohorts. Given the very small sample size and the incomplete availability of endothelial cell count data, these findings should be regarded as preliminary.